Clinical Trial 49138

Marlton, NJ 08053


Summary:

A Phase 1, Randomized, Double Blind, Placebo Controlled, Serial Cohort Dose Escalation Study to assess the safety, tolerability, and pharmacokinetics of single oral doses of AT-1082 in Healthy Nonsmoking Adults.


Qualified Participants Must:

• Be 18-55 years old
• Have BMI between 18-32
• Be a poor metabolizer of CYP2D6 Enzyme
• Be a nonsmoker


Qualified Participants May Receive:

Compensation for time and travel.

Transportation provided and No insurance needed.

 


Available At:

Hassman Research Institute
30 Lake Center Drive
Marlton, NJ 08053
View Clinic Location

 


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.